Bright Minds Biosciences (DRUG) EPS (Basic): 2020-2021
Historic EPS (Basic) for Bright Minds Biosciences (DRUG) over the last 1 years, with Sep 2021 value amounting to -$1.33.
- Bright Minds Biosciences' EPS (Basic) fell 1716.79% to -$1.33 in Q3 2021 from the same period last year, while for Sep 2021 it was -$0.81, marking a year-over-year change of. This contributed to the annual value of -$0.76 for FY2021, which is 885.37% down from last year.
- According to the latest figures from Q3 2021, Bright Minds Biosciences' EPS (Basic) is -$1.33, which was down 629.20% from $0.25 recorded in Q2 2021.
- In the past 5 years, Bright Minds Biosciences' EPS (Basic) registered a high of $0.25 during Q2 2021, and its lowest value of -$1.33 during Q3 2021.
- In the last 2 years, Bright Minds Biosciences' EPS (Basic) had a median value of $0.09 in 2020 and averaged -$0.15.
- Data for Bright Minds Biosciences' EPS (Basic) shows a maximum YoY slumped of 1,716.79% (in 2021) over the last 5 years.
- Quarterly analysis of 2 years shows Bright Minds Biosciences' EPS (Basic) stood at $0.09 in 2020, then tumbled by 1,716.79% to -$1.33 in 2021.
- Its EPS (Basic) was -$1.33 in Q3 2021, compared to $0.25 in Q2 2021 and $0.18 in Q1 2021.